A prospective cohort study of thrombotic thrombocytopenic purpura and atypical hemolytic uremic syndrome patients who have presented with their acute episode and are in remission within the last 30 days. They will be followed for 12 months from the time of their initial scan, followed by a long-term follow up study.
The investigators will conduct a prospective cohort study at the London Health Sciences Centre, Ontario, Canada. The investigators will identify 15-30 idiopathic thrombotic thrombocytopenic purpura and atypical hemolytic uremic syndrome patients who are in remission within the last 30 days. They will be followed for 12 months from the time of their remission. Study procedures include routine laboratory monitoring, biomarker assessments, cardiovascular and neurocognitive functional assessments, and non-invasive imaging studies. The long-term follow-up thrombotic thrombocytopenic purpura and atypical hemolytic uremic syndrome study will help to assess the mechanisms of vascular injuries, evaluate cardiovascular and cerebrovascular monitoring tools, and generate novel ideas to prevent further vascular injuries.
Study Type
OBSERVATIONAL
Enrollment
35
Brain and cardiac CT perfusion scan
Speckle tracking Echocardiography
Cambridge Brain Sciences neuro-cognitive assessment
London Health Sciences Centre
London, Ontario, Canada
RECRUITINGvascular events affecting the brain and heart
The investigators will report the proportion of patients who have functional and/or structural vascular events affecting the brain and heart, after the first acute idiopathic TTP events
Time frame: 0-12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
MRI to assess white matter changes